Clinical Trials Directory

Trials / Completed

CompletedNCT00102232

Effect of Phosphatidylcholine on Plasma Homocysteine in Healthy Volunteers

Effect of Choline Supplemented as Phosphatidylcholine on Post-Methionine Loading and Fasting Concentrations of Plasma Homocysteine in Healthy Volunteers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
26 (planned)
Sponsor
Wageningen Centre for Food Sciences · Academic / Other
Sex
Male
Age
50 Years – 71 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether supplementation with phosphatidylcholine lowers plasma homocysteine concentrations in healthy men.

Detailed description

A high homocysteine concentration is a potential risk for cardiovascular disease. Plasma homocysteine concentrations can be lowered through betaine supplementation. However, effects of choline supplementation, the precursor for betaine, on plasma homocysteine concentrations in healthy humans are unknown. If supplementation with choline or phosphatidylcholine, the form in which choline occurs in foods, lowers homocysteine concentrations, then extra intake of these compounds may lower cardiovascular disease risk in humans. Comparison: We compared the effects of supplementation with phosphatidylcholine to the effects of a placebo on fasting and post-methionine concentrations of plasma homocysteine in healthy men.

Conditions

Interventions

TypeNameDescription
PROCEDUREsupplementation with phosphatidylcholine

Timeline

Start date
2003-05-01
Completion
2003-07-01
First posted
2005-01-26
Last updated
2005-06-24

Locations

2 sites across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00102232. Inclusion in this directory is not an endorsement.